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Carotid MR angiography with traditional bolus
timing: clinical observations and Fourier-based
modelling of contrast kinetics
Abstract This study analyses the
relation between image quality and
contrast kinetics in bolus-timed
carotidmagneticresonanceangiography
(MRA) and interprets the findings by
Fourier-based numerical modelling.
One hundred patients prone to carotid
stenosis were studied using contrast-
enhanced carotid MRAwith bolus
timing.ThecarotidMRAsweretimedto
start relatively early without accounting
for the injection time of the contrast
medium. For interpretation different
starting times were modelled, utilising
the spectral information of the test bolus
series. In the test bolus series the arterial
time-to-peak showed a large 95%
confidence interval of 12–27 s,
indicating the need for individual MRA
timing. All bolus-timed MRAs were of
good diagnostic quality. The mean
(±SD) arterial contrast-to-noise ratio
was 53.0 (±12.8) and thus high, and
95% of the MRAs showed a slight
venous contamination of 11.8% or less
( m e d i a n5 . 6 % ) .A c c o r d i n gt ot h e
Fourier-based modelling the central
k-space may be acquired about 2 s
before the arterial contrast peak. This
resultsincarotidMRAswithsufficiently
high arterial enhancement and little
venous contamination. In conclusion, in
bolus-timed carotid MRA a relatively
short timing provides good arterial
contrast with little venous
contamination, which can be explained
by Fourier-based numerical modelling
of the contrast kinetics.
Keywords Carotid artery disease .
Magnetic resonance angiography .
Contrast enhancement . Dynamic .
Fourier analysis
Abbreviations 3D: three-
dimensional . CNR: contrast-to-noise
ratio . MR: magnetic resonance .
MRA: MR angiography .
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Introduction
In carotid artery disease contrast-enhanced magnetic
resonance (MR) angiography has become a noninvasive
imaging alternative for catheter angiography [1–3]. The
major task of carotid MRA is to assess carotid artery
stenosis. Severe carotid stenosis (70−99% according to
NASCETcriteria) is a major risk factor in ischaemic stroke,
causing about 20% of cases [4]. Surgical endarterectomy
and transluminal angioplasty make it a treatable risk factor
[5, 6].
According to two current meta-analyses, gadolinium-
enhanced carotid MRA has a high sensitivity of about 94%
and a high specificity of about 92% for the diagnosis of
severe carotid artery stenosis [7, 8]. Both meta-analyses
treated gadolinium-enhanced carotid MRA as one entity,
although this entity comprises several competitive methods.
The three major methods are bolus-timed MRA, fluorosco-
pically triggered MRA and temporally resolved MRA.
These MRA methods have similar diagnostic accuracy for
the diagnosis of severe carotid stenosis; thus, they may be
equally applied and further developed [7, 8].
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kinetics of bolus-timed carotid MRA, which is the
traditional method. The observations in a patient collective
with a relatively early acquisition of the contrast-enhanced
MRA sequence are reported. Such short timing was applied
to minimise venous enhancement while obtaining suffi-
cient arterial enhancement. To explain the findings, bolus-
timed carotid MRA was modelled by Fourier-based
numerical simulations that utilise the dynamic contrast
information of the bolus time series.
Materials and methods
Patients
This study includes 100 prospectively collected carotid
MRAs from 100 different consecutive patients with
suspected or known carotid stenosis, thus representing a
random sample from a high-risk patient collective. Seven
additional carotid MRAs were excluded from the study: six
were follow-up MRAs in the same patients and one MRA
had major motion artefacts. These MRAs were replaced by
consecutive MRAs to obtain the planned number of 100
MRAs. Within the study group the male-to-female ratio
was 70:30, ages ranged from 44 to 86 years (median
70 years) and body weights ranged from 47 to 108 kg
(median 78 kg). The local ethics committee waived ethical
approval on this study of image quality. Informed patient
consent for MRA had been obtained. All MRA sequences
were acquired solely for clinical reasons.
Bolus-timed carotid MRA
The carotid MRA were performed using 1.5-T magnets
(Magnetom Symphony and Sonata, Siemens, Germany)
with a phased-array neck coil. The patient was placed head-
first in the magnet. After multiplanar TruFISP localisers,
the individual vein-to-carotid circulation time was mea-
sured by using a 2-ml gadolinium DTPA test bolus
(gadopentetate dimeglumine, Magnevist, Schering, Ger-
many). With an MR injector (Spectris Medrad, Indianola,
USA) this test bolus was injected at a flow of 3 ml/s into an
antecubital vein, followed by a 25-ml saline flush at the
same flow rate. Simultaneously, a time series of 40
transverse two-dimensional MR images near the carotid
bifurcation was started with one image obtained per second
(FLASH 2D, TR 1,000 ms, TE 1.59 ms, flip angle 8°, FOV
256×256 pixels, isotropic voxel size 1.37×1.37 mm). The
MR technician placed regions of interest (ROIs) in the
carotids of this bolus time series and read the arterial time-
to-peak from the resulting time–signal curves. Then the
supra-aortic arteries were imaged from the aortic arch to the
circle of Willis with a breath-hold three-dimensional (3D)
gradient echo sequence, resulting in 72 adjacent coronal
slices (FLASH 3D, TR 3.54 ms, TE 1.39 ms, flip angle 25°,
FOV 320×208 pixels, isotropic voxel size 1.1×1.1×
1.1 mm, acquisition time 21 s). This 3D sequence was
used with sequential k-space ordering and multidimen-
sional 6/8 partial-Fourier acquisition in phase and slice
encoding directions. According to the sequence parameter
menu this 3D-MRA sequence reaches its k-space centre
after 8.3 s, which is slightly more than one third of the total
acquisition time. First, such a 3D sequence was measured
unenhanced. Then 0.2 ml/kg of gadolinium DPTA was
intravenously injected and flushed with 25 ml of saline,
both at a flow of 3 ml/s. A subsequent bolus-timed,
gadolinium-enhanced 3D sequence was started, so that the
central k-space acquisition coincided with the measured
arterial time-to-peak from the bolus time series, using the
following simple timing formula with Tdelta=0 s:
Tstart ¼ Tart peak   Tk centre þ Tdelta timing formula ðÞ
with
Tstart starting time of the 3D sequence after beginning
the gadolinium injection
Tart-peak individual arterial time-to-peak, as determined
by the test bolus series
Tk-centre time when the 3D sequence reaches its k-space
centre, here rounded to 8 s
Tdelta delta time, for adding or subtracting any further
timing factors
Usually, it is recommended to let Tdelta account for the
injection time of the MRA gadolinium bolus [9, 10]. At a
constant flow rate of 3 ml/s, the test bolus (2-ml volume)
reaches its temporal centre after 0.3 s, while the MRA bolus
(about 15-ml volume) reaches its temporal centre after about
2.5 s. Thus, for optimal arterial enhancement it would be
necessary to add the difference of Tdelta=2.5−0 . 3=2 . 2st o
the starting time. However, the later the gadolinium-enhanced
3Dsequencestarts,thehigher therisk of venousenhancement
because of gadolinium that returns from the cranial circula-
tion. In the study group Tdelta was set to 0 s as a compromise
between sufficient arterial contrast and little venous contam-
ination. After this bolus-timed acquisition of the gadolinium-
enhanced 3D-MRA imagesthe unenhanced 3D-MRA images
were subtracted to suppress the background MR signal from
surrounding neck tissue. From this subtracted 3D-MRA
targeted maximum intensity projections (MIP) were derived
to selectively depict the left and right supra-aortic arteries.
Radiological diagnosis was based on the MIP images and on
the original 3D images. The MRA images were stored in the
PACS archive in the original DICOM format.
Programs for postprocessing
For this study the MR images were converted from the
DICOM format to the ANALYZE format by using the free
2655medical image viewer MRIcro (MRIcro 1.40, http://www.
mricro.com). This program was also used for viewing
images and drawing ROIs. Further postprocessing was
done with proprietary programs written in C++6.0
(Microsoft Corporation). Some of these programs utilised
the free software FFTW (FFTW 3.1.2., http://www.fftw.
org) for converting MR images to their spatial frequency
domain (k-space) and vice versa by forward and backward
Fourier transform [11].
ROI measurements
Different ROI measurements were performed for image
analysis as described below. To avoid interobserver vari-
ability, all ROIs were placed by the same author. This is
consistentwith the methods ofseveralother studies[12–14].
Additionallythiscorrespondstoclinicalpractice,whereROI
measurements are usually performed by one radiologist.
Analysis of test bolus time series
In each individual test bolus series, ROIs were manually
placed at the carotid arteries and the internal jugular veins.
From corresponding arterial and venous time–signal curves
different timing parameters were determined, as defined by
Table 1 in conjunction with Fig. 1. These included the
arterial time-to-peak (Tart-peak) and other arterial, venous
and mixed arteriovenous circulation times.
Analysis of carotid MRA
The angiographic enhancement of the carotid MRA
(Fig. 2) was quantified by arterial and venous contrast-to-
noise ratios (CNR). From the subtracted 3D-MRA a
transverse plane was reformatted at the level of the test
bolus sequence. On both sides of the neck ROIs were
placed in the carotid arteries, internal jugular veins, neck
muscles and in the air outside the neck. The arterial CNR,
venous CNR and venous contamination were determined
as follows:
CNRarterial ¼ SIcarotids   SImuscle ðÞ

SDair arterial CNR ðÞ
CNRvenous ¼ SIveins   SImuscle ðÞ

SDair venous CNR ðÞ
Contamvenous ¼ SIveins=SIcarotids venous contamination ðÞ
with
SIcarotids mean signal intensity in the carotids
SIveins mean signal intensity in the internal jugular
veins
SImuscle mean signal intensity in the neck muscles
SDair standard deviation of voxel intensities in the air
The amount of venous contamination was given as a
percentage.
Modelling of bolus-timed carotid MRA
To explain the findings in the study group, bolus-timed
carotid MRAs were modelled with different starting times
for the 3D sequence in each individual. This modelling was
solely based on clinical MRA images. No additional
gadolinium was applied for this study. The modelling of
bolus-timed MRA includes firstly, modelling the MRA
bolus time series, and secondly, modelling the carotid MRA.
Modelling of MRA bolus time series
The test bolus had a 2-ml volume and was injected at a flow
of 3 ml/s in less than 1 s. Within the study group the MRA
Table 1 Contrast dynamics of the test bolus in the study group
Timing parameter Mean (95% CI) (s) Time interval
a Symbol Calculation
Arterial time-to-begin 13.6 (8.5 to 18.7) 0 to A TA
Arterial time-to-peak (Tart-peak) 19.4 (12.0 to 26.9) 0 to B TB
Arterial time-to-end 29.2 (18.8 to 39.6) 0 to C TC
Venous time-to-begin 21.8 (14.1 to 29.5) 0 to D TD
Venous time-to-peak 29.5 (20.0 to 38.9) 0 to E TE
Arterial test bolus duration 15.6 (9.1 to 22.1) A to C TF =TC−TA
Pure arterial time-before-peak 5.8 (2.6 to 9.1) A to B TG =TB−TA
Pure arterial time-after-peak 2.4 (−0.5 to 6.2) B to D TH =TD−TB
Arteriovenous time-to-begin 8.2 (4.4 to 12.0) A to D TI =TD−TA
Arteriovenous time-to-peak 10.0 (6.1 to 14.0) B to E TJ =TE−TB
aThe timing parameters correspond to the symbols A to E in Fig. 1. The intravenous injection of gadolinium started at 0 s
2656bolus for the subsequent gadolinium-enhanced 3D-MRA
had a volume of about 15 ml and was injected in about 5 s.
In all 100 cases the MRA bolus was modelled by
superimposing temporally shifted time–signal curves of
the test bolus as illustrated in Fig. 3. In detail, the MRA
bolus was modelled as a 40-s time series, as follows. The
first 10 images of the test bolus time series were averaged
to give an unenhanced mask image, similar to the mask
image in digital subtraction angiography (DSA). This mask
image was subtracted from the test bolus time series,
similar to generating a series of DSA subtraction images.
Such subtraction images retain the gadolinium-associated
signal intensities, while the unenhanced background signal
is subtracted. Several of these subtracted time series images
were temporally shifted and superimposed to simulate the
intravenous injection of 15 ml gadolinium within 5 s.
Afterwards, the mentioned mask image was added again,
so that the modelled MRA bolus time series also contained
background signal. In these modelled MRA bolus time
series the arterial and venous time–signal curves were
calculated with the same ROIs as in the test bolus series.
This was possible because these ROIs had been stored by
the program MRIcro for such further applications.
Modelling of carotid MRA
The modelled MRA bolus time series were also used for
modelling the arteriovenous contrast dynamics of carotid
MRA with different starting times by varying Tdelta in the
Fig. 2 Illustrative carotid MRA. Carotid MRA in the illustrative
case: a coronal maximum intensity projection; b targeted volume
rendering of an 80% stenosis of the proximal left internal carotid
artery; c transverse plane of the 3D-MRA showing the right
common carotid artery (CCA), vertebral artery (VA) and internal
jugular vein (IJV). The arteries are well enhanced. The IJV shows a
ringing
Fig. 3 Modelling of MRA bolus kinetics. The gadolinium bolus for
the 3D-MRA was of larger volume and was injected over a longer
period than the test bolus. Five time-shifted test bolus time–signal
curves (thin lines, normalised to 3 ml of gadolinium DTPA) were
superimposed to model the arterial and venous time–signal curves of
a 5-s-long MRA bolus with 15 ml of gadolinium DTPA (upper thick
lines). The resulting arterial curve peaked at 20 s and thus 2 s later
than with the shorter test bolus. The maximum MR signal on the y-
axis has been normalised to 1
Fig. 1 Illustrative test bolus. Arterial and venous time–signal curves
of the test bolus in a 68-year-old man. The test bolus reached the
carotids at 13 s (A arterial time-to-begin), peaked with its MR signal
at Tart-peak=18s(B arterial time-to-peak) and had passed the carotids
at approximately 30 s (C arterial time-to-end). Marked enhancement
of the internal jugular veins started at 21 s (D venous time-to-begin)
and peaked at 27 s (E venous time-to-peak)
2657timing formula. For this purpose a sequential acquisition
with a 21-s duration and 81% partial-Fourier (i.e. slightly
more than 6/8 = 75%) was modelled, as illustrated in Fig. 4
[11]. This modelled sequence reaches its k-space centre
after Tk-centre=8 s, which is approximately similar to the
8.3 s of the real MRA sequence that was applied in the
patients.ThearterialCNR,thevenousCNRandtheamount
ofvenouscontaminationofthemodelledcarotidMRAwere
calculated with the same ROIs as in the MRA bolus time
series. This modelling of carotid MRA is restricted to the
two-dimensional plane of the bolus time series. However,
the signal intensities of the real 3D-MRA were also
evaluated in this transverse plane, so that the two-dimen-
sional modelling ofthis MRAplane is considered sufficient
for explaining the arteriovenous contrast dynamics of the
3D-MRA in this study.
Results
Illustrative case
Figure 1 presents the arterial and venous time–signal
curves of the gadolinium test bolus in a 68-year-old man
with an 80% stenosis of the proximal left internal carotid
artery. The 2-ml test bolus had been intravenously injected
in less than 1 s. Because of intravascular dispersion the
bolus is prolonged to 17-s duration (A to C) while flowing
from the antecubital vein through the cardiopulmonary
circulation to the carotids. The peak arterial signal (B) was
reached at Tart-peak=18 s and the time window of pure
arterial enhancement (A to D) was 8 s, which is
representative of the study group. Marked enhancement
of the internal jugular veins started at 21 s (D), i.e. 3 s after
the arterial peak. These contrast kinetics illustrate that the
optimal timing of carotid MRA depends on a few seconds.
The subsequent gadolinium-enhanced 3D-MRA was
planned to start at Tstart=10 s, i.e. with Tdelta=0 s, according
to the timing formula. Thus, not only the mixed arterial-
venous signal after the arterial peak (after B), but also the
5 s of pure arterial signal before the arterial peak (from A to
B), was used for angiographic imaging.
Figure 2 shows a coronal MIP image of the subsequent
3D-MRA. The cervical arteries are well demonstrated with
a high arterial CNR (contrast-to-noise ratio) of 61.8.
Although the gadolinium bolus was well timed, there is
already venous enhancement with a venous CNR of 3.4 in
the internal jugular veins, causing slight venous contam-
ination of 8.7% on the MRA image. In Fig. 2c the arteries
are homogeneously enhanced, whereas the internal jugular
vein (IJV) shows a typical ringing, as if it had been
spatially high-pass filtered.
Fig. 4 Modelling of gadolinium-enhanced MRA acquisition in the
illustrative case, if it had been started at Tstart=12 s to achieve the
highest possible arterial contrast: a modelled transverse 2D MRA
images at different times after the beginning of intravenous injection
of gadolinium; b by fast Fourier transform the MR images are
transformed to their spatial frequency domain (k-space); c modelling
a 21-s MRA sequence with slightly more than 6/8 partial-Fourier
acquisition (with 81% instead of 75% k-space coverage) by linking
the dark-marked k-space segments in b from different times and
different spatial frequencies; d postprocessed k-space image with
Hermitian symmetry; e inverse Fourier transform of d gives the final
MRA image as modelled with the 21-s sequence; f the common
carotid artery (CCA) and the vertebral artery (VA) are homo-
geneously contrasted with their highest possible arterial signal.
However, the modelled MRA image already shows some venous
enhancement in the internal jugular vein (IJV) with a typical ringing,
similar to the observed ringing in Fig. 2c
2658Observations in the study group
Table 1 summarises the test bolus dynamics in the study
group. The arterial enhancement peak is considered
optimal for acquisition of the central k-space. Therefore,
the arterial time-to-peak (Tart-peak) was used for bolus
timing. In the study group the average Tart-peak was
19.4 s. However, this Tart-peak varied considerably among
patients (95% confidence interval 12.0–26.9 s), indicating
the need for individual timing of the gadolinium-
enhanced 3D-MRA sequence. In the study group the
arterial test bolus lasted on average 15 s. Of this, the
initial time window of pure arterial enhancement was on
average 8 s, before the venous enhancement started. Of
note, the venous enhancement started on average only
2.4 s after the arterial peak, and peaked itself 10 s later.
This early venous enhancement explains why even an
optimally timed 3D-MRA sequence may show some
venous contamination.
Table 2 summarises the image quality parameters of the
3D-MRA in the study group. The arterial contrast-to-noise
ratio (CNR) was generally very high, so that the cervical
arteries were well depicted on angiographic maximum
intensity projection (MIP) images. In most cases the
venous enhancement and thus the venous contamination
was small. A few cases showed venous contamination of
up to 16.3%. However, this relatively small amount of
venous contamination did not hinder visualisation of the
arteries, because the arterial MR signals were still much
higher than the venous MR signals. All 100 MRAs were
of diagnostic quality, and all arteries were homoge-
neously contrasted without ringing signs. In the cases
with highest venous enhancement the veins typically
showed a marginal ringing enhancement (Fig. 2c). As
mentioned in Material and methods, only one MRA had
been excluded from the study because of major motion
artefacts, but not because of insufficient arterial contrast
or excessive venous enhancement.
Modelling of bolus-timed carotid MRA
in the illustrative case
The time series of the short test bolus (2 ml of gadolinium
DTPA injected in less than 1 s) was used to model the
contrast kinetics of the longer MRA bolus (about 15 ml of
gadolinium DTPA injected in 5 s). Figure 3 shows this
modelling in the illustrative case. The modelled arterial
signal of the longer MRA bolus peaked at 20 s, and thus 2 s
later than in the test bolus (Tart-peak=18 s). According to this
modelled MRA bolus the carotid MRA should be started
with Tdelta = +2 s to achieve the highest possible arterial
contrast. With the timing formula the optimal starting time
would then be Tstart=18−8+2=12 s after the beginning of
the intravenous injection of gadolinium.
Figure 4 shows the modelling of bolus-timed carotid
MRA with this starting time in the illustrative case. The
modelled arteries are homogeneously and well contrasted.
However, the modelled internal jugular vein is also
somewhat enhanced and shows a typical ringing in
Fig. 4f that was also observed in the real measured carotid
MRA in Fig. 2c. This venous ringing occurs when the vein
is initially unenhanced, but fills with gadolinium during
acquisition of the final high-frequency components of the
peripheral k-space. This can be seen in Fig. 4a and b
between 24 and 32 s after the beginning of the intravenous
injection of gadolinium. Thus, in the MRA image this
venous enhancement can only contribute to high-frequency
waves. This is why the internal jugular vein in the
measured (Fig. 2c) and in the modelled (Fig. 4f) carotid
MRA seems to have been spatially high-pass filtered. The
primary bolus images in Fig. 4a do not show this venous
ringing because of a much shorter acquisition time per
image.
Modelling of different MRA starting times
The modelling of carotid MRAwith different starting times
is shown in Fig. 5a for the illustrative patient and in Fig. 5b
for the study group.
In the illustrative case (Fig. 5a) the MRA sequence had
originally been planned to start at Tstart=18−8=10 s
according to the timing formula, i.e. Tdelta=0 s. With this
early MRA timing the modelled arterial MR signal is about
84% of its theoretical maximum, and the modelled venous
MR signal is 3.9% of the maximal arterial signal. This
results in a modelled venous contamination of 4.7%.
However, with this Tdelta=0 s the arterial signal does not
reach its theoretical maximum. This overall maximum is
reached 2 s later, which is consistent with Fig. 3. When
considering these 2 s, the MRA should be started with
Tdelta=2 s, i.e. at Tstart=18−8+2=12 s after the beginning
of the gadolinium injection. In this case the k-space centre
is acquired while the arterial gadolinium concentration of
the MRA bolus is highest. However, because of the early
Table 2 Image quality of the 3D-MRAs in the study group
Arterial
CNR
a
Venous
CNR
a
Venous
contamination (%)
a
Mean 53.0 1.2 6.4
SD 12.8 1.9 2.7
Minimum 31.9 −1.1 2.5
5th percentile 34.9 −0.6 3.4
Median 51.7 0.7 5.6
95th percentile 74.6 5.3 11.8
Maximum 98.1 10.6 16.3
aCNR and venous contamination are defined in Material and
methods
2659venous return of gadolinium the resulting venous contam-
ination is then already 7.2%. If the MRA acquisition is
further delayed by an additional 2 s,the MRAwould start at
Tdelta=4 s, i.e. at Tstart=18−8+4=14 s after the beginning
of the intravenous injection of gadolinium. According to
the model, the venous contamination is then already about
17% (Fig. 5a). The real acquired 3D-MRA in the
illustrative case showed venous contamination of 8.7%
(Fig. 2). Perhaps this 3D-MRA had been acquired with a
Tdelta of about 2 s, and thus slightly later than planned.
Both parts of Fig. 5 are relatively similar, which
indicates that the considerations about different MRA
starting times in the illustrative patient can be transferred to
the study group. In summary this modelling of contrast
kinetics shows that the timing of gadolinium-enhanced
carotid MRA is sensitive to a few seconds. A relatively
short timing with Tdelta=0 s is a compromise that provides
sufficient arterial contrast with little venous contamination.
Discussion
In carotid artery disease contrast-enhanced magnetic
resonance (MR) angiography is a well-established non-
invasive imaging method [1–3]. Several methods exist to
achieve high arterial contrast with little venous contami-
nation, which much depends on contrast kinetics. The
gadolinium chelates are usually injected into an antecubital
vein. Although being injected in less than 1 s, the test bolus
duration is prolonged to about 15 s (95% CI 9–22 s) while
flowing through the cardiopulmonary circulation to the
carotids. Because of this bolus dispersion there is generally
no risk that the time window of carotid enhancement is too
short, even if the MRA bolus is injected at a high flow of
about 3 ml/s in a few seconds. The major temporal
limitation of this arterial acquisition window originates
from venous enhancement because of gadolinium that
returns from the cranial circulation: the pure arterial time
window lasted on average only 8 s in the study group,
which is quite short.
Because of the fast cervicocranial circulation the timing
of carotid MRA depends on a few seconds, as indicated by
this study and by others [9, 10]. Basically this is well
known. However, this study adds considerations about
venous contamination of the MRA images. Usually it is
recommended to let the acquisition of the central k-space
coincide with the arterial bolus peak to achieve the highest
arterial MR signal [9, 10]. However, in carotid MRA this
general rule does not account for venous contamination
because of early venous return from the cranial circulation.
In the presented study the carotid MRA was started
relatively early with Tdelta=0 s according to the timing
formula. This does not account for the fact that the MRA
bolus had more volume and thus needed about 2 s longer to
reach its peak than the test bolus. According the Fourier-
based modelling the carotid MRAs thus achieved only
about 84% of the maximal possible arterial contrast.
However, with this relatively early acquisition of the 3D-
MRA the observed venous contamination was on average
small, so that Tdelta=0 s offers a clinically useful
compromise between sufficient arterial contrast and little
venous contamination.
All studied carotid MRA showed a high arterial contrast-
to-noise ratio (CNR) and homogeneously enhanced arteries
without ringing. This indicates that the 3D-MRA had not
been started too early, and that the central k-space of the
Fig. 5 Modelling of bolus-timed MRA showing the arterial and
venous MR signals and the percentage of venous contamination of
the modelled carotid MRA at different starting times a in the
illustrative case, and b in the whole study groups after coherent
averaging of the individual Tdelta. The MR signals are normalised to
1 for the maximal possible arterial MR signal. With Tdelta=0 s the
venous contamination is relatively small and the arterial signal is
sufficiently high. Further details are given in Results
26603D-MRA was acquired sufficiently near to the arterial
enhancement peak. When the internal jugular veins were
slightly enhanced, they typically showed a ringing that can
be explained well by Fourier-based modelling (Figs. 2c and
4f). Generally the venous contamination was sufficiently
small and did not hinder visualization of the well-enhanced
arteries.
This study did not intend to compare bolus-timed MRA
with other competitive MRA techniques. In gadolinium-
enhanced carotid MRA there seems to be no simple rule
that predicts an optimum in the complex relation between
diagnostic accuracy and different MRA parameter settings.
Such parameters include the type of MRA timing,
sequence duration, k-space acquisition order, spatial reso-
lution, gadolinium bolus details, and others. For example,
several studies have been published about the sensitivity
and specificity of carotid MRA in the diagnosis of severe
carotid stenosis. These studies utilized a broad variety of
different MRA parameter settings that are in clinical use.
With all these different methods the diagnostic accuracy of
carotid MRA was generally excellent, independent of the
applied MRA settings. In this context, the results of bolus-
timed MRA, fluoroscopically triggered MRA and time-
resolved MRA were all good. The traditional bolus-timed
carotid MRA offers the same high diagnostic accuracy as
the other MRA timing methods and should thus not be
excluded from further technical developments.
The obtained carotid MRAs in the study group are
observations and are as such not limited. However, the
explanatory modelling of contrast kinetics is based on
simulations, which are generally known to fit the reality not
always exactly. A more exact approach would have been to
study real contrast kinetics with several different starting
times Tstart in each patient. According to the timing
formula, the data for Fig. 5b could then be obtained by
measuring 11 bolus time series in each patient, while
varying Tdelta from −4 to +6 s and injecting about 15 ml
gadolinium DTPA for each measurement. This would
necessitate a total dose of 165 ml gadolinium DTPA per
patient. However, then the study would have an experi-
mental instead of its observational character. For the
presented observational study the numerical modelling of
the gadolinium contrast kinetics is considered to be
sufficient, because this modelling is solely used to explain
the clinical findings with Tdelta=0 s. A further study
limitation is that the arteriovenous contrast kinetics is only
modelled for a two-dimensional transverse plane of the
neck. It would be desirable to measure and model the
contrast kinetics not only with a two-dimensional but also
with a three-dimensional sequence at similar spatiotempor-
al resolution. This might be achieved with parallel imaging
and a very high acceleration factor.
Recently carotid MRA with parallel imaging has been
reported with a sixfold acceleration factor [15]. Interest-
ingly this study also used partial-Fourier acquisition and
bolus timing, indicating that bolus-timed carotid MRA is
not an outdated technology [15]. Such high-resolution
carotid MRA could further help to diagnose carotid artery
disease without radiation, and might thus aid in the
framework of stroke prevention [5, 6, 16]. Bolus timing
might remain part of such MRA techniques, when it is the
aim to fully exploit the arterial contrast bolus with planned
little venous contamination.
Conclusion
In bolus-timed carotid MRA a relatively short timing
provides good arterial contrast with little venous contam-
ination, which can be explained by Fourier-based numer-
ical modelling of the contrast kinetics.
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permits any noncommercial use, distribution, and reproduction in
any medium, provided the original author(s) and source are credited.
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